Sertraline for the Treatment of Depression in Vascular Cognitive Impairment

Gali H. Weissberger, Brandon C. Yarns, Stephen T. Chen, Theresa Narvaez, Natalya Bussel, David L. Sultzer

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)908-909
Number of pages2
JournalAmerican Journal of Geriatric Psychiatry
Volume26
Issue number8
DOIs
StatePublished - Aug 2018
Externally publishedYes

Bibliographical note

Funding Information:
Supported in part by Pfizer, Inc. (investigator-initiated award) and the U.S. Department of Veterans Affairs . Dr. Yarns was supported by the VA Office of Academic Affiliations through the VA National Clinician Scholars Program (funding ID TPH 65-005 ). Dr. Weissberger was supported by the Office of Academic Affiliations , Department of Veterans Affairs, through the Geriatric Research Education and Clinical Center , Advanced Fellowship in Geriatrics . These contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government.

Funding

Supported in part by Pfizer, Inc. (investigator-initiated award) and the U.S. Department of Veterans Affairs . Dr. Yarns was supported by the VA Office of Academic Affiliations through the VA National Clinician Scholars Program (funding ID TPH 65-005 ). Dr. Weissberger was supported by the Office of Academic Affiliations , Department of Veterans Affairs, through the Geriatric Research Education and Clinical Center , Advanced Fellowship in Geriatrics . These contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government.

FundersFunder number
Geriatric Research Education and Clinical Center
Office of Academic Affiliations
Pfizer, Inc.
VA National Clinician Scholars ProgramTPH 65-005
VA Office of Academic Affiliations
U.S. Department of Veterans Affairs

    Cite this